M&A Rebound Hopes Derailed by Recession Fears

A widening valuation gap is leaving otherwise healthy companies stranded in aging private-equity portfolios.

Cellares provides automated clinical and commercial manufacturing services for cell and gene therapies.

Infrastructure managers are raising ever-larger funds to acquire power plants and grid assets, betting that electricity will become one of the scarcest commodities of the AI era.